News
Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the ...
A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid ...
In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
1d
Zacks Investment Research on MSNHow Will Pfizer's Oncology Drugs Perform in Q2 Earnings?Pfizer PFE is one of the biggest players in the oncology space — a position it strengthened with the 2023 acquisition of ...
Pfizer Inc. (NYSE:PFE) is one of the Best Large Cap Value Stocks to Invest In. Morningstar reduced its moat rating for the ...
1d
Zacks.com on MSNPfizer (PFE) Stock Sinks As Market Gains: Here's WhyPfizer (PFE) concluded the recent trading session at $25.35, signifying a -1.17% move from its prior day's close.
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
A federal court dismissed a journalist’s claims against Pfizer executives and a member of the former Biden Administration for ...
This was the stock's second consecutive day of losses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results